TrialBMJ global health2020

Cost-effectiveness analysis of tranexamic acid for the treatment of traumatic brain injury, based on the results of the CRASH-3 randomised trial: a decision modelling approach.

Jack Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.